CSIMarket
 


Davita Inc   (DVA)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

DVA's Revenue Growth by Quarter and Year

Davita Inc 's Revenue results by quarter and year




DVA Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 2,905.32 2,898.58 2,821.12
III Quarter September - 2,924.07 2,904.08 2,847.33
II Quarter June - 2,879.98 2,842.71 2,886.95
I Quarter March 2,820.00 2,841.24 2,743.11 5,466.06
FY   2,820.00 11,550.61 11,388.48 14,021.46



DVA Revenue first quarter 2021 Y/Y Growth Comment
Davita Inc reported decrease in Revenue in the first quarter by -0.75% to $ 2,820.00 millions, from the same quarter in 2020.
The decrease in the first quarter Davita Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.49%.

Looking into first quarter results within Healthcare Facilities industry 7 other companies have achieved higher Revenue growth. While Davita Inc ' s Revenue decline of -0.75% ranks overall at the positon no. 533 in the first quarter.




DVA Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 0.23 % 2.75 % 115.44 %
III Quarter September - 0.69 % 1.99 % -56.5 %
II Quarter June - 1.31 % -1.53 % -55.2 %
I Quarter March -0.75 % 3.58 % -49.82 % -11.63 %
FY   - 1.42 % -18.78 % -31.55 %

Financial Statements
Davita Inc 's first quarter 2021 Revenue $ 2,820.00 millions DVA's Income Statement
Davita Inc 's first quarter 2020 Revenue $ 2,841.24 millions Quarterly DVA's Income Statement
New: More DVA's historic Revenue Growth >>


DVA Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - -0.64 % -0.19 % -0.92 %
III Quarter September - 1.53 % 2.16 % -1.37 %
II Quarter June - 1.36 % 3.63 % -47.18 %
I Quarter March -2.94 % -1.98 % -2.77 % 317.43 %
FY (Year on Year)   - 1.42 % -18.78 % -31.55 %




Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #8
Healthcare Sector #51
Overall #533

Revenue Y/Y Growth Statistics
High Average Low
152.13 % 3.49 % -22.82 %
(Dec 31 2013)   (Sep 30 2018)
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #8
Healthcare Sector #51
Overall #533
Revenue Y/Y Growth Statistics
High Average Low
152.13 % 3.49 % -22.82 %
(Dec 31 2013)   (Sep 30 2018)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Davita Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
317.43 % 9.46 % -79.99 %
(Mar 31 2018)  


DVA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Davita Inc reported fall in Revenue from the previous quarter by -2.94% to $ 2,820.00 millions, from $ 2,905.32 millions achived in the previous reporting period.

It's not huge concern, as I. Quarter Revenue always gravitate to dip in this quarter Ana Alves, Healthcare sector insider noted.

Within Healthcare Facilities industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Davita Inc 's Revenue growth quarter on quarter, overall rank is 473.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #7
Healthcare Sector #35
Overall #473
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #7
Healthcare Sector #35
Overall #473
Revenue Q/Q Growth Statistics
High Average Low
317.43 % 9.46 % -79.99 %
(Mar 31 2018)  


DVA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Davita Inc realized fall in Revenue from the previous quarter by -2.94% to $ 2,820.00 millions, from $ 2,905.32 millions released in the previous reporting period.

But that's not important issue, as Revenue generally seem to slow in the I. Quarter.

Within Healthcare Facilities industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Davita Inc 's Revenue growth quarter on quarter, overall rank is 473.


Davita Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Revenue 12 Months Ending $ 11,529.37 $ 11,550.60 $ 11,606.71 $ 11,523.88 $ 11,486.60
Y / Y Revenue Growth (TTM) 0.37 % 1.42 % 3.13 % 2.4 % 1.66 %
Year on Year Revenue Growth Overall Ranking # 387 # 289 # 1554 # 1400 # 0
Seqeuential Revenue Change (TTM) -0.18 % 0.06 % 0.71 % 0.32 % 0.86 %
Seq. Revenue Growth (TTM) Overall Ranking # 533 # 398 # 642 # 1149 # 0




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2021 period, Davita Inc 's cumulative twelve months Revenue were $ 11,529 millions, company would post below average annual Revenue growth of 0.86% year on year, if the fiscal year would end at Mar 31 2021.
A slow-down in the Davita Inc 's Revenue growth from the 2905.32% growth in Dec 31 2020.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 289 to 387.

Revenue TTM Q/Q Growth Statistics
High Average Low
152.13 %
3.49 %
-22.82 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 8
Healthcare Sector # 35
Overall # 387

Revenue TTM Y/Y Growth Statistics
High Average Low
329.48 %
19.21 %
-50.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 51
S&P 500 # 533
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2021 period, Davita Inc 's cumulative twelve months Revenue were $ 11,529 millions, company would post below average annual Revenue growth of -50.85% year on year, if the fiscal year would end at Mar 31 2021.
A slow-down in the Davita Inc 's Revenue growth from the 2905.32% growth in Dec 31 2020.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 289 to 387.

Revenue TTM Q/Q Growth Statistics
High Average Low
152.13 %
3.49 %
-22.82 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 8
Healthcare Sector # 35
Overall # 387

Revenue TTM Y/Y Growth Statistics
High Average Low
329.48 %
19.21 %
-50.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 51
S&P 500 # 533




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DVA's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for DVA's Competitors
Revenue Growth for Davita Inc 's Suppliers
Revenue Growth for DVA's Customers

You may also want to know
DVA's Annual Growth Rates DVA's Profitability Ratios DVA's Asset Turnover Ratio DVA's Dividend Growth
DVA's Roe DVA's Valuation Ratios DVA's Financial Strength Ratios DVA's Dividend Payout Ratio
DVA's Roa DVA's Inventory Turnover Ratio DVA's Growth Rates DVA's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2021
Neurocrine Biosciences Inc -0.21%$ -0.211 millions
U S Physical Therapy Inc-0.31%$ -0.310 millions
Community Health Systems Inc -0.40%$ -0.397 millions
Davita Inc -0.75%$ -0.747 millions
Travere Therapeutics Inc -0.76%$ -0.758 millions
Neurometrix Inc -0.76%$ -0.763 millions
Amneal Pharmaceuticals Inc -0.80%$ -0.799 millions
Inogen Inc -1.76%$ -1.760 millions
National Healthcare Corp-2.01%$ -2.011 millions
Tactile Systems Technology Inc -2.07%$ -2.068 millions
Eyepoint Pharmaceuticals Inc -2.22%$ -2.217 millions
Mimedx Group Inc -2.87%$ -2.865 millions
Anika Therapeutics Inc -3.12%$ -3.122 millions
Biomarin Pharmaceutical Inc-3.19%$ -3.195 millions
Icu Medical Inc-3.21%$ -3.214 millions
Horizon Therapeutics Public Limited Company-3.79%$ -3.794 millions
Novabay Pharmaceuticals Inc -4.49%$ -4.493 millions
Prestige Consumer Healthcare Inc -5.36%$ -5.363 millions
Transmedics Group Inc -6.33%$ -6.335 millions
Lifevantage Corp-8.04%$ -8.037 millions
Amarin Corp Plcuk-8.27%$ -8.273 millions
Teva Pharmaceutical Industries Ltd-8.61%$ -8.607 millions
Healthcare Services Group Inc -9.22%$ -9.217 millions
Five Star Senior Living Inc -9.53%$ -9.529 millions
Msa Safety Inc-9.59%$ -9.590 millions
Atrion Corporation-10.15%$ -10.150 millions
Invacare Corporation-10.18%$ -10.180 millions
Eagle Pharmaceuticals inc -10.37%$ -10.367 millions
Omeros Corporation-10.52%$ -10.520 millions
Clovis Oncology inc -10.60%$ -10.598 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JCS's Profile

Stock Price

JCS's Financials

Business Description

Fundamentals

Charts & Quotes

JCS's News

Suppliers

JCS's Competitors

Customers & Markets

Economic Indicators

JCS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071